Aristotelis Agianniotis1, Marios Anthimopoulos1, Elena Daskalaki1, Aurélie Drapela1, Christoph Stettler2, Peter Diem2, Stavroula Mougiakakou3. 1. Diabetes Technology Research Group, ARTORG Center for Biomedical Engineering Research, University of Bern, Switzerland. 2. Department of Endocrinology, Diabetes & Clinical Nutrition, Bern University Hospital "Inselspital," Bern, Switzerland. 3. Diabetes Technology Research Group, ARTORG Center for Biomedical Engineering Research, University of Bern, Switzerland Department of Endocrinology, Diabetes & Clinical Nutrition, Bern University Hospital "Inselspital," Bern, Switzerland stavroula.mougiakakou@artorg.unibe.ch.
Abstract
BACKGROUND: In an artificial pancreas (AP), the meals are either manually announced or detected and their size estimated from the blood glucose level. Both methods have limitations, which result in suboptimal postprandial glucose control. The GoCARB system is designed to provide the carbohydrate content of meals and is presented within the AP framework. METHOD: The combined use of GoCARB with a control algorithm is assessed in a series of 12 computer simulations. The simulations are defined according to the type of the control (open or closed loop), the use or not-use of GoCARB and the diabetics' skills in carbohydrate estimation. RESULTS: For bad estimators without GoCARB, the percentage of the time spent in target range (70-180 mg/dl) during the postprandial period is 22.5% and 66.2% for open and closed loop, respectively. When the GoCARB is used, the corresponding percentages are 99.7% and 99.8%. In case of open loop, the time spent in severe hypoglycemic events (<50 mg/dl) is 33.6% without the GoCARB and is reduced to 0.0% when the GoCARB is used. In case of closed loop, the corresponding percentage is 1.4% without the GoCARB and is reduced to 0.0% with the GoCARB. CONCLUSION: The use of GoCARB improves the control of postprandial response and glucose profiles especially in the case of open loop. However, the most efficient regulation is achieved by the combined use of the control algorithm and the GoCARB.
BACKGROUND: In an artificial pancreas (AP), the meals are either manually announced or detected and their size estimated from the blood glucose level. Both methods have limitations, which result in suboptimal postprandial glucose control. The GoCARB system is designed to provide the carbohydrate content of meals and is presented within the AP framework. METHOD: The combined use of GoCARB with a control algorithm is assessed in a series of 12 computer simulations. The simulations are defined according to the type of the control (open or closed loop), the use or not-use of GoCARB and the diabetics' skills in carbohydrate estimation. RESULTS: For bad estimators without GoCARB, the percentage of the time spent in target range (70-180 mg/dl) during the postprandial period is 22.5% and 66.2% for open and closed loop, respectively. When the GoCARB is used, the corresponding percentages are 99.7% and 99.8%. In case of open loop, the time spent in severe hypoglycemic events (<50 mg/dl) is 33.6% without the GoCARB and is reduced to 0.0% when the GoCARB is used. In case of closed loop, the corresponding percentage is 1.4% without the GoCARB and is reduced to 0.0% with the GoCARB. CONCLUSION: The use of GoCARB improves the control of postprandial response and glucose profiles especially in the case of open loop. However, the most efficient regulation is achieved by the combined use of the control algorithm and the GoCARB.
Authors: A S Brazeau; H Mircescu; K Desjardins; C Leroux; I Strychar; J M Ekoé; R Rabasa-Lhoret Journal: Diabetes Res Clin Pract Date: 2012-11-10 Impact factor: 5.602
Authors: Melanie K Bothe; Luke Dickens; Katrin Reichel; Arn Tellmann; Björn Ellger; Martin Westphal; Ahmed A Faisal Journal: Expert Rev Med Devices Date: 2013-08-23 Impact factor: 3.166
Authors: Melanie B Gillingham; Zoey Li; Roy W Beck; Peter Calhoun; Jessica Castle; Mark Clements; Eyal Dassau; Francis J Doyle; Robin L Gal; Peter Jacobs; Susana R Patton; Michael R Rickels; Michael Riddell; Corby K Martin Journal: Diabetes Technol Ther Date: 2020-09-29 Impact factor: 6.118